Chronic Obstructive Pulmonary Disease Diagnosis and Management in Older Adults
- 1 June 2010
- journal article
- review article
- Published by Wiley in Journal of the American Geriatrics Society
- Vol. 58 (6) , 1153-1162
Abstract
Chronic obstructive pulmonary disease (COPD) in older adults is a complex disorder with several unique age‐related aspects. Underlying changes in pulmonary lung function and poor sensitivity to bronchoconstriction and hypoxia with advancing age can place older adults at greater risk of mortality or other complications from COPD. The establishment of the Global Initiative for Obstructive Lung Disease criteria, which can be effectively applied to older adults, has more rigorously defined the diagnosis and management of COPD. An important component of this approach is the use of spirometry for disease staging, a procedure that can be performed in most older adults. The management of COPD includes smoking cessation, influenza and pneumococcal vaccinations, and the use of short‐ and long‐acting bronchodilators. Unlike with asthma, corticosteroid inhalers represent a third‐line option for COPD. Combination therapy is frequently required. When using various inhaler designs, it is important to note that older adults, especially those with more‐severe disease, may have inadequate inspiratory force for some dry‐powder inhalers, although many older adults find the dry‐powder inhalers easier to use than metered‐dose inhalers. Other important treatment options include pulmonary rehabilitation, oxygen therapy, noninvasive positive airway pressure, and depression and osteopenia screening. Clinicians caring for older adults with an acute COPD exacerbation should also guard against prognostic pessimism. Although COPD is associated with significant disability, there is a growing range of treatment options to assist patients.Keywords
This publication has 39 references indexed in Scilit:
- A 4-Year Trial of Tiotropium in Chronic Obstructive Pulmonary DiseaseNew England Journal of Medicine, 2008
- Long-term decline in lung function, utilisation of care and quality of life in modified GOLD stage 1 COPDThorax, 2008
- COPD as a Systemic DiseaseCOPD: Journal of Chronic Obstructive Pulmonary Disease, 2008
- Ipratropium bromide versus long-acting beta-2 agonists for stable chronic obstructive pulmonary diseaseCochrane Database of Systematic Reviews, 2006
- Inability to draw intersecting pentagons as a predictor of unsatisfactory spirometry technique in elderly hospital inpatientsAge and Ageing, 2006
- Inflammatory markers are associated with ventilatory limitation and muscle dysfunction in obstructive lung disease in well functioning elderly subjectsThorax, 2005
- Non-invasive positive pressure ventilation for treatment of respiratory failure due to severe acute exacerbations of asthma2005
- Risk of Mortality and Heart Failure Exacerbations Associated With Inhaled β-Adrenoceptor Agonists Among Patients With Known Left Ventricular Systolic DysfunctionaChest, 2003
- Short report. Do patient age and medical condition influence medical advice to stop smoking?Age and Ageing, 2000
- Effects of theophylline and ipratropium on cognition in elderly patients with chronic obstructive pulmonary diseaseAnnals of Allergy, Asthma & Immunology, 1996